Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

Core Viewpoint - Alpha Tau Medical Ltd. has appointed Ms. Maya Netser to its Board of Directors, marking a significant leadership change as the company expands its cancer treatment capabilities [1][2]. Company Overview - Alpha Tau Medical Ltd. is an Israeli oncology therapeutics company founded in 2016, focusing on the research, development, and potential commercialization of the Alpha DaRT technology for treating solid tumors [6]. - The Alpha DaRT technology utilizes radium-224 for targeted alpha-irradiation of tumors, aiming to minimize damage to surrounding healthy tissue [8]. Leadership Changes - Ms. Maya Netser brings over 25 years of experience in corporate leadership and advisory roles, including her previous position as CEO of Cabaret Biotech, which was acquired by Kite Pharma and Gilead Sciences [2][3]. - Mr. Meir Jakobsohn has completed his term on the Board but will continue to serve in an advisory capacity, having contributed significantly to the company's growth [4][5]. Strategic Direction - The company is at a strategic inflection point, focusing on expanding its treatment capabilities to internal organs, which is seen as a promising opportunity for growth [2].